Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
This is where medications like semaglutide may provide meaningful benefit
Legal Disclaimer This product is sold as a pure research compound and is not intended for human consumption or use as a dietary supplement, drug, or treatment
When comparing tirzepatide to semaglutide, at first glance tirzepatide offers a slight advantage in terms of efficacy for weight loss
Buyer Takeaway: Trimi doesn't prescribe to you - Arora Health's licensed clinicians do, independently
Key Milestones Timeline Eli Lillys Strategic Context Retatrutides development occurs within Eli Lillys broader metabolic disease portfolio, which also includes tirzepatide (approved as Mounjaro for type 2 diabetes and Zepbound for obesity) and orforglipron (an oral GLP-1R agonist in Phase 3 development)
